158 related articles for article (PubMed ID: 17718271)
1. The association of stromal mast cell response and tumor cell differentiation in colorectal cancer.
Taweevisit M
J Med Assoc Thai; 2006 Sep; 89 Suppl 3():S69-73. PubMed ID: 17718271
[TBL] [Abstract][Full Text] [Related]
2. The relationship between the stromal mast cell number, microvessel density, c-erbB-2 staining and survival and prognostic factors in colorectal carcinoma.
Elezoğlu B; Tolunay S
Turk Patoloji Derg; 2012; 28(2):110-8. PubMed ID: 22627628
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer.
Gulubova M; Vlaykova T
J Gastroenterol Hepatol; 2009 Jul; 24(7):1265-75. PubMed ID: 17645466
[TBL] [Abstract][Full Text] [Related]
4. Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas.
Acikalin MF; Oner U; Topçu I; Yaşar B; Kiper H; Colak E
Dig Liver Dis; 2005 Mar; 37(3):162-9. PubMed ID: 15888280
[TBL] [Abstract][Full Text] [Related]
5. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
6. [Effects of mast cell infiltration on the development and metastasis of gastric carcinoma].
Liu YL; Zhao MQ; Hou G; Miao F; Liu W
Di Yi Jun Yi Da Xue Xue Bao; 2005 Jul; 25(7):809-11. PubMed ID: 16027074
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of microvessel density and mast cell density for the survival of Thai patients with primary colorectal cancer.
Yodavudh S; Tangjitgamol S; Puangsa-art S
J Med Assoc Thai; 2008 May; 91(5):723-32. PubMed ID: 18672639
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of early colorectal carcinoma with lymph node metastatic disease.
Son HJ; Song SY; Lee WY; Yang SS; Park SH; Yang MH; Yoon SH; Chun HK
Hepatogastroenterology; 2008; 55(85):1293-7. PubMed ID: 18795675
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
[TBL] [Abstract][Full Text] [Related]
10. Tumor budding in colorectal carcinomas.
Sert Bektaş S; Inan Mamak G; Cırış IM; Bozkurt KK; Kapucuoğlu N
Turk Patoloji Derg; 2012; 28(1):61-6. PubMed ID: 22207434
[TBL] [Abstract][Full Text] [Related]
11. Histological variants of colorectal adenocarcinoma and clinicomorphological association.
Wisedopas N; Thirabanjasak D; Chirakalwasan N; Taweevisit M
J Med Assoc Thai; 2006 Jun; 89(6):788-94. PubMed ID: 16850678
[TBL] [Abstract][Full Text] [Related]
12. Analysis of pathological risk factors for lymph node metastasis in colorectal cancer.
Fang W; Fan B; Xiong B
Hepatogastroenterology; 2009; 56(91-92):663-6. PubMed ID: 19621676
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in survival of colorectal cancer patients after surgery.
Mehrkhani F; Nasiri S; Donboli K; Meysamie A; Hedayat A
Colorectal Dis; 2009 Feb; 11(2):157-61. PubMed ID: 18462239
[TBL] [Abstract][Full Text] [Related]
14. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract][Full Text] [Related]
15. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths.
Ogawa T; Yoshida T; Tsuruta T; Tokuyama W; Adachi S; Kikuchi M; Mikami T; Saigenji K; Okayasu I
Scand J Gastroenterol; 2009; 44(5):605-14. PubMed ID: 19221929
[TBL] [Abstract][Full Text] [Related]
16. The lymphatic infiltration identified by D2-40 monoclonal antibody predicts lymph node metastasis in submucosal invasive colorectal cancer.
Kawaura K; Fujii S; Murata Y; Hasebe T; Ishii G; Itoh T; Sano Y; Saito N; Ochiai A
Pathobiology; 2007; 74(6):328-35. PubMed ID: 18087197
[TBL] [Abstract][Full Text] [Related]
17. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
[TBL] [Abstract][Full Text] [Related]
18. Upstaging benefits and accuracy of sentinel lymph node mapping in colorectal adenocarcinoma nodal staging.
Quadros CA; Lopes A; Araujo I; Fregnani JH; Fahel F
J Surg Oncol; 2008 Oct; 98(5):324-30. PubMed ID: 18618578
[TBL] [Abstract][Full Text] [Related]
19. Histological grading of colorectal cancer: a simple and objective method.
Ueno H; Mochizuki H; Hashiguchi Y; Ishiguro M; Kajiwara Y; Sato T; Shimazaki H; Hase K; Talbot IC
Ann Surg; 2008 May; 247(5):811-8. PubMed ID: 18438118
[TBL] [Abstract][Full Text] [Related]
20. Malignant adenoma: diagnosis, staging, risk factors, lymph node involvement and problems of sampling.
Risio M; Fiocca R
Tech Coloproctol; 2004 Dec; 8 Suppl 2():s253-6. PubMed ID: 15666101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
